Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FBPZY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,374
Award facts
- Contract value 100% obligated
- $27,374.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,374 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 52 mg Mirena systems. The contract, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain and operates under a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to military healthcare facilities worldwide.
This delivery order represents one of numerous purchase orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division for a diverse portfolio of pharmaceuticals, medical consumables, and specialty products. As a regional prime vendor contractor under the PPV-G GEN V program, which commenced on November 13, 2025, and extends through December 31, 2036, DMS Pharmaceutical Group is authorized to supply branded and generic prescription medications, biologics, vaccines, and medical devices to support recurring medical supply needs across the Department of Defense's global military healthcare operations. The company's established performance on numerous delivery orders demonstrates its capacity to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBPZY?
SPE2DR26FBPZY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FBPZY worth?
The government has obligated $27,374 on SPE2DR26FBPZY.
Is contract SPE2DR26FBPZY an order under another contract?
Yes. SPE2DR26FBPZY is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPZY competed?
The extent of competition for SPE2DR26FBPZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award